6ix — Find Your Next Investment

Discover investor relations events, company profiles, and opportunities on 6ix. Connect with public companies and attend live investor events.

Please enable JavaScript to use all features of 6ix.com.

Oorspronkelijke tekst

Deze vertaling beoordelen

Je feedback wordt gebruikt om Google Translate te verbeteren

Latest Press Releases

Time	Headline
29m ago	Sunrun Prices $584 million Securitization of Residential Solar and Storage Assets
29m ago	Madison Air Schedules First Quarter 2026 Earnings Conference Call and Webcast
53m ago	Ultra Clean Announces Retirement of the Chief Financial Officer Sheri Savage
53m ago	GridAI Technologies Corp. Announces Receipt of NASDAQ Notice Regarding Late Form 10-K Filing
53m ago	Rush Enterprises, Inc. Reports First Quarter 2026 Results, Announces $0.19 Per Share Dividend

About

Cardiol Therapeutics Inc Class A (TO:CRDL) — investor relations, events, news, and company updates on 6ix.

Latest News

Cardiol Therapeutics Expands U.S. MAVERIC Phase III Trial Network to Address Growing Interest in the Pivotal Program

Cardiol Therapeutics to Highlight MAVERIC Phase III Trial and Recently Published ARCHER Results in Live Interview with Barchart

Cardiol Therapeutics Announces Year-End 2025 Update on Operations

Cardiol Therapeutics to Present at TD Cowen 46th Annual Health Care Conference

Cardiol Therapeutics' ARCHER Phase II Study Results Published in ESC Heart Failure

Financials

Revenue

CA$0

Market Cap

CA$221.13 M

EPS

-0.39

Community Chat

Ask AI